Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Menorest approved in 29 markets

Feb. 12, 1997

AGE inhibitors reported by Alteon

Feb. 12, 1997

Sparta expands clinical trials of retinoid

Feb. 11, 1997

Sumitomo develops ACAT inhibitors

Feb. 11, 1997

Hypoglycemic/hypolipidemic agents from Kyorin

Feb. 11, 1997

Sankyo develops antidiabetic agents

Feb. 11, 1997

Structure of protease involved in osteoporosis solved

Feb. 10, 1997

Unigene Laboratories reveals bioequivalency results for osteoporosis drug

Feb. 7, 1997

Alza signs licensing agreements for transdermal testesterone products

Feb. 7, 1997

Progress in Bone Care's vitamin D pipeline

Feb. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026